EMA Says Benefits Outweigh The Clots Potentially Linked To Johnson & Johnson Vaccine

The European Medicines Agency concluded there is a possible link between the Johnson & Johnson vaccine and rare, unusual blood clots, saying the benefits of the vaccine outweigh the very rare risks.